3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
10
Hot Flashes
2
Anxiety Disorders
2
Vomiting
1
Testicular Germ Cell Tumor
1
Smoking Cessation
1
Sarcoma
1
Pathophobia
1
Pain
1
Ovarian Neoplasms
1
Nausea
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Inflammatory Breast Neoplasms
1
Gastrointestinal Neoplasms
1
Emotional Regulation
1
Depression
1
Breast Carcinoma In Situ
1
Breast Cancer Surgery
1
Affective Symptoms
1
Interventions
Flow Cytometry
3
Cyclophosphamide
3
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Immunologic Techniques
2
Etoposide
2
Busulfan
2
Alemtuzumab
2
sargramostim
1
fludarabine phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
aldesleukin
1
Thiotepa
1
Tacrolimus
1
Psychiatric Rehabilitation
1
Prednisone
1
Nicotine
1
Moxifloxacin
1
Microarray Analysis
1
Melphalan
1
Levofloxacin
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Interferon-alpha
1
Immunoenzyme Techniques
1
Hypnosis
1
Granisetron
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Germ Cell Tumor
×
Hypnosis
×
Breast
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled